198 related articles for article (PubMed ID: 6104837)
1. Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.
Liebman J; Neale R
Psychopharmacology (Berl); 1980; 68(1):25-9. PubMed ID: 6104837
[TBL] [Abstract][Full Text] [Related]
2. Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys.
Neale R; Gerhardt S; Liebman JM
Psychopharmacology (Berl); 1984; 82(1-2):20-6. PubMed ID: 6320248
[TBL] [Abstract][Full Text] [Related]
3. Progressive changes in the acute dyskinetic syndrome as a function of repeated elicitation in squirrel monkeys.
Neale R; Gerhardt S; Fallon S; Liebman JM
Psychopharmacology (Berl); 1982; 77(3):223-8. PubMed ID: 6126906
[TBL] [Abstract][Full Text] [Related]
4. Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance.
Murphy CA; Feldon J
Behav Pharmacol; 2000 Jun; 11(3-4):307-16. PubMed ID: 11103885
[TBL] [Abstract][Full Text] [Related]
5. Acute dyskinesias in monkeys elicited by halopemide, mezilamine and the "antidyskinetic" drugs, oxiperomide and tiapride.
Neale R; Fallon S; Gerhardt S; Liebman JM
Psychopharmacology (Berl); 1981; 75(3):254-7. PubMed ID: 6798615
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-induced acute dyskinesias in rhesus monkeys.
Porsolt RD; Jalfre M
Psychopharmacology (Berl); 1981; 75(1):16-21. PubMed ID: 6117919
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction.
Liebman JM; Gerhardt SC; Gerber R
Psychopharmacology (Berl); 1989; 97(4):456-61. PubMed ID: 2524857
[TBL] [Abstract][Full Text] [Related]
8. Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug.
Migler BM; Warawa EJ; Malick JB
Psychopharmacology (Berl); 1993; 112(2-3):299-307. PubMed ID: 7871034
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
Sayers AC; Bürki HR; Ruch W; Asper H
Psychopharmacology (Berl); 1976 Dec; 51(1):15-22. PubMed ID: 13446
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
Carlson KR; Eibergen RD
Ann N Y Acad Sci; 1976; 281():336-49. PubMed ID: 828468
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates.
Casey DE
Psychopharmacology (Berl); 1993; 112(1 Suppl):S55-9. PubMed ID: 7831441
[TBL] [Abstract][Full Text] [Related]
13. Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
Eibergen RD; Carlson KR
Pharmacol Biochem Behav; 1976 Aug; 5(2):175-87. PubMed ID: 825885
[TBL] [Abstract][Full Text] [Related]
14. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
Gunne LM; Bárány S
Psychopharmacology (Berl); 1979 Jun; 63(3):195-8. PubMed ID: 39307
[TBL] [Abstract][Full Text] [Related]
15. SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models.
Gerhardt S; Gerber R; Liebman JM
Life Sci; 1985 Dec; 37(25):2355-63. PubMed ID: 3908866
[TBL] [Abstract][Full Text] [Related]
16. Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics.
Casey DE
Psychopharmacol Bull; 1991; 27(1):47-50. PubMed ID: 1677773
[TBL] [Abstract][Full Text] [Related]
17. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration.
Gao XM; Hashimoto T; Cooper TB; Tamminga CA
J Neural Transm (Vienna); 1997; 104(1):97-104. PubMed ID: 9085197
[TBL] [Abstract][Full Text] [Related]
18. Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat.
Trevitt J; Atherton A; Aberman J; Salamone JD
Psychopharmacology (Berl); 1998 May; 137(1):61-6. PubMed ID: 9631957
[TBL] [Abstract][Full Text] [Related]
19. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs.
Marsden CD; Jenner P
Psychol Med; 1980 Feb; 10(1):55-72. PubMed ID: 6104342
[TBL] [Abstract][Full Text] [Related]
20. PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects.
Corbin AE; Meltzer LT; Ninteman FW; Wiley JN; Christoffersen CL; Wustrow DJ; Wise LD; Pugsley TA; Heffner TG
Neuropharmacology; 2000 Apr; 39(7):1211-21. PubMed ID: 10760363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
